SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001356576-20-000006
Filing Date
2020-02-11
Accepted
2020-02-11 16:07:57
Documents
16
Period of Report
2020-02-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k4q192x11earningsre.htm   iXBRL 8-K 41138
2 EXHIBIT 99.1 ex9912-11x2020.htm EX-99.1 9747
8 LOGO logoa05.jpg GRAPHIC 5496
  Complete submission text file 0001356576-20-000006.txt   203620

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20200211.xsd EX-101.SCH 4582
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20200211_cal.xml EX-101.CAL 620
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20200211_def.xml EX-101.DEF 1470
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20200211_lab.xml EX-101.LAB 26141
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20200211_pre.xml EX-101.PRE 13576
11 EXTRACTED XBRL INSTANCE DOCUMENT a8-k4q192x11earningsre_htm.xml XML 4344
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 20596646
SIC: 2834 Pharmaceutical Preparations